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SUMMARY
Lack of sensitive single-cell analysis tools has limited the characterization of metabolic activity in 
cancer stem cells. By hyperspectral stimulated Raman scattering imaging of single living cells and 
mass spectrometry analysis of extracted lipids, we report here significantly increased levels of 
unsaturated lipids in ovarian cancer stem cells (CSCs) as compared to non-CSCs. Higher lipid 
unsaturation levels were also detected in CSC-enriched spheroids compared to monolayer cultures 
of ovarian cancer cell lines or primary cells. Inhibition of lipid desaturases effectively eliminated 
CSCs, suppressed sphere formation in vitro, and blocked tumor initiation capacity in vivo. 
Mechanistically, we demonstrate that NF-κB directly regulates the expression levels of lipid 
desaturases and that inhibition of desaturases blocks NF-κB signaling. Collectively, our findings 
reveal that increased lipid unsaturation is a metabolic marker for ovarian CSCs and a target for 
CSC-specific therapy.
Graphical abstract
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INTRODUCTION
Cancer stem cells (CSCs), also recognized as tumor initiating cells, represent a small 
population of cancer cells that have the ability to self-renew and initiate tumors in vivo 
(Bjerkvig et al., 2005). CSCs are resistant to conventional therapies and are responsible for 
tumor relapse after chemotherapy (Jordan et al., 2006; Pattabiraman and Weinberg, 2014) 
and development of distant metastases (Jordan et al., 2006). Understanding their unique 
characteristics and vulnerabilities will enable the development of CSC-targeting therapies 
with the ultimate goal of overcoming tumor relapse and metastasis.
Recent studies have focused on blocking signaling pathways or genetic programs that fuel 
cellular “stemness”. For example, epithelial to mesenchymal transition (EMT) is emerging 
as a key program in CSCs required for initiation of metastasis (Visvader and Lindeman, 
2008a). Related signaling pathways, like Wnt and transforming growth factor β (TGF-β), 
are recognized as new targets for CSC-specific therapy (Pattabiraman and Weinberg, 2014). 
The Hedgehog and Notch pathways implicated in the self-renewal of CSCs (Zhou et al., 
2009) are being targeted and specific inhibitors have recently entered clinical development. 
In ovarian cancer, the Mullerian Inhibiting Substance was proposed as a potential targeting 
strategy for chemotherapy resistant CSCs (Meirelles et al., 2012; Szotek et al., 2006). 
However, as the development of technologies enabling the study of rare populations has 
lagged, one underexplored niche remains understanding the CSC metabolism.
So far, only limited studies have begun to address this niche. A recent report suggested that 
glucose played an important role maintaining the side population in non-small lung and 
colon cancer models and that inhibition of glycolysis blocked this population (Liu et al., 
2014). A few studies have linked lipogenesis to CSCs. Specifically, inhibition of fatty acid 
synthase was shown to suppress the growth of breast cancer stem-like cells in vivo (Pandey 
et al., 2011); the peroxisome proliferator-activated receptor γ (PPARγ) pathway was found 
important in maintaining the CSC properties of ERBB2-positive breast cancer cells partly by 
upregulating the de novo lipogenic pathway (Wang et al., 2013), and increased numbers of 
lipid droplets were identified in colorectal CSCs compared to differentiated cancer cells 
(Tirinato et al., 2015). Collectively, these studies point to lipogenesis as a potentially altered 
metabolic process in CSCs, but the precise mechanism by which lipids regulate stemness 
remains unknown.
In this study, we identify and characterize lipid unsaturation in ovarian CSCs by chemical 
imaging of single living cells through recently developed hyperspectral stimulated Raman 
scattering (SRS) microscopy (Cheng and Xie, 2015; Zhang et al., 2015). This single-cell 
imaging study and mass spectrometry analysis show a significantly increased level of lipid 
unsaturation in flow-sorted ovarian CSCs (ALDH+/CD133+) compared to non-CSCs 
(ALDH−/CD133−) and in ovarian cancer (OC) cells growing as spheres compared to 
monolayers. Inhibition of lipid desaturases, either Δ9 (SCD1) or Δ6, impaired cancer cell 
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stemness, suppressed sphere formation, and prevented tumor formation in vivo. We further 
identified the NF-κB pathway as a critical mechanism through which lipid desaturase 
inhibitors perturb the functions of CSCs. Collectively, our findings put forward lipid 
desaturation as a metabolic marker of ovarian CSCs and as a new target for CSC-specific 
therapy.
RESULTS
Increased lipid unsaturation in isolated ovarian CSCs compared to non-CSCs
We employed hyperspectral SRS microscopy to quantitatively analyze the composition of 
intracellular lipids inside single cells. ALDH+/CD133+ cells, which have been previously 
described as cells possessing CSC characteristics (Flesken-Nikitin et al., 2014; Foster et al., 
2013), were isolated from COV362, an ovarian cancer (OC) cell line. By tuning the Raman 
shift frame by frame, 50 images of individual ALDH−/CD133− and ALDH+/CD133+ 
COV362 cells were recorded at the C-H vibration region from 2800 to 3050 cm−1 with a 
step size of ~5 cm−1 (Supplemental movie 1, 2). Inside each cell, the C-H bond rich lipid 
droplets were highlighted in the context of relatively weaker signals from protein and 
nucleotides. Initial analysis of the images at 2850 cm−1, where the CH2 symmetric stretch 
vibration resides, revealed an increase of total amount of lipid droplets in ALDH+/CD133+ 
cells. An in-depth comparison revealed that lipid droplets in ALDH+/CD133+ cells had a 
stronger signal at 3002 cm−1 than those in ALDH−/CD133− cells (Fig. 1A). As the peak at 
3002 cm−1 is known to be from the vibration of =C-H bonds mostly in unsaturated lipids 
(Movasaghi et al., 2007), our data suggests that ALDH+/CD133+ CSC cells have a higher 
level of unsaturated lipids. To eliminate the influence of the total number of C-H bonds, we 
used the peak around 2900 cm−1, contributed by C-H stretch vibrations in all the lipids 
(Movasaghi et al., 2007), to normalize the SRS intensity at 3002 cm−1. After normalization, 
the ratio of SRS intensity at 3002 cm−1 to that at 2900 cm−1 (I3002/I2900) was found to be 
significantly higher in ALDH+/CD133+ cells than that in ALDH−/CD133− cells (Fig. 1A). 
The difference of the peak intensity at 3002 cm−1 became more obvious when we plotted 
together the SRS spectra from different lipid droplets (Fig. 1B). Quantitatively, we found a 
statistically significant difference between the two groups in terms of lipid unsaturation level 
(Fig. S1A).
To confirm the above observation, we acquired full Raman spectra from individual LDs in 
both C-H stretch and fingerprint vibration regions. After normalization by the CH2 bending 
vibration peak at 1450 cm−1, the Raman spectra clearly showed that the peak at 1264 cm−1 
(in plane bending motion of =C-H), the peak at 1660 cm−1 (stretching vibration of C=C), 
and the peak at 3002 cm−1 (vibration of =C-H) in ALDH+/CD133+ cells were higher than 
those in ALDH−/CD133− cells (Fig. 1C). In consistence with the hyperspectral SRS imaging 
data, the height ratios of the peak at 3002 cm−1 to the peak at 1450 cm−1 (Fig. 1D), 1660 
cm−1 to 1450 cm−1 (Fig. S1B), and 1264 cm−1 to 1450 cm−1 (Fig. S1C) all showed a 
significant increase of lipid unsaturation level in ALDH+/CD133+ cells. To ensure that the 
findings are not cell line specific, we compared ALDH+/CD133+ and ALDH−/CD133− 
populations isolated from OVCAR5 cells. After normalization by the 1450 cm−1 peak, 
higher peak intensities at 1264 cm−1, 1660 cm−1 and 3002 cm−1 were noted in ALDH+/
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CD133+ OVCAR5 cells compared to ALDH−/CD133− OVCAR5 cells (Fig. 1E). 
Quantitatively, the height ratio of the peak at 3002 cm−1 to the peak at 1450 cm−1 was 
significantly higher in CSCs compared to non-CSCs (Fig. 1F). These results collectively 
demonstrate increased lipid unsaturation in ovarian CSCs compared to non-CSCs.
Increased lipid unsaturation in spheroids compared to monolayer cultures
It is known that CSCs have the ability to proliferate as spheres when cultured under non-
adherent conditions (Ponti et al., 2005; Zhou and Zhang, 2008). Thus, we utilized CCS-rich 
spheroids as a second model to validate our observations. Hyperspectral SRS imaging was 
conducted to analyze lipid composition of COV362 cells grown either as monolayers or as 
spheres under similar serum-free conditions (Supplemental movie 3, 4). Using the intensity 
ratio between 3002 cm−1 and 2900 cm−1, we observed an increased unsaturation level in 
spheres compared to monolayer cultures (Fig. 2A). As most cells in spheroids showed 
higher levels of unsaturation, it is possible that both CSCs and other progenitor cells present 
in spheres are rich in unsaturated lipids (Ponti et al., 2005). Comparison of SRS spectral 
profile (Fig. 2B) and quantitative analysis of the intensity ratio (I3002/I2900) (Fig. S2A) 
further confirmed the difference in lipid unsaturation levels between monolayers and 
spheres. Based on the height ratio of the peak at 3002 cm−1 to the peak at 1450 cm−1, 
Raman spectral analysis of COV362, OVCAR5, and primary cells derived from malignant 
OC ascites (total 4 patients, Table S1) quantitatively demonstrates elevated lipid unsaturation 
levels in spheres compared to monolayers cells (Fig. 2C).
Although the SRS imaging and Raman spectral analysis focused on lipid droplets, which are 
storage sites of neutral lipids mainly in the form of triglycerides and sterol esters, we 
speculated that the increased unsaturation in lipid droplets was part of an altered lipid 
metabolic network in CSCs. To test the hypothesis, we performed whole lipid analysis by 
mass spectrometry. First, we extracted free fatty acids from cells grown as monolayers or 
spheres (Ma and Xia, 2014) and analyzed by Electrospray Ionization Mass Spectrometry 
(ESI-MS). As shown in the mass spectra (Fig. S2B), the major components of free fatty 
acids in both monolayer and sphere cultures derived from OVCAR5 cells were 18:1 (e.g., 
oleic acid) and 18:0 (e.g., stearic acid). When normalized by the peak intensity of 18:0, the 
peak intensity of 18:1 in spheres was found to be significantly higher than that in cells 
grown as monolayers (Fig. S2C). Consistent results were obtained in COV362 (Fig. S2D) 
and primary OC cells isolated from malignant OC ascites (Fig. S2E, F). Furthermore, using 
Liquid Chromatography-Mass Spectrometry (LC-MS), we performed a more quantitative 
and comprehensive analysis of fatty acids saponified from all lipids (Kamphorst et al., 
2013). The levels of all measured saponfied fatty acids, including palmitic (16:0), 
palmitoleic (16:1), stearic (18:0), oleic (18:1), linoleic (18:2), arachidonic (20:4), and 
docosahexaenoic acid (22:6), were significantly increased in cells grown as spheres 
compared to monolayer cultures (Fig. 2D, S2G). These data are consistent with the proposed 
phenomenon of increased de novo lipogenesis in CSCs. Moreover, the ratio of unsaturated 
fatty acids (UFA) to saturated fatty acids (SFA) was significantly increased in COV362 (Fig. 
2E) and OVCAR5 (Fig. S2H) cells grown as spheres, confirming the increased unsaturation 
level in lipid droplets measured by Raman spectral analysis. These results suggest that 
unsaturation level in lipid droplets can be used as a readout of intracellular activities of 
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desaturases. Taken together, the increased lipid unsaturation in ovarian CSCs was validated 
through hyperspectral SRS imaging, Raman spectroscopy, and mass spectrometry, in 
different CSC models derived from cell lines and primary OC cells.
The increased lipid unsaturation is mediated by lipid desaturases
Intracellular lipids originate either from the uptake of extracellular lipids or through de novo 
synthesis. We have shown higher levels of lipid unsaturation in both flow-sorted 
ALDH+CD133+ cells grown in the presence of serum (Fig. 1 and Fig. S1) and in spheroids 
grown in serum-free medium (Fig. 2 and Fig. S2). To determine the source of increased 
unsaturated lipids in CSCs, we examined the contribution of de novo synthesis, which is 
mediated by three fatty acid desaturases Δ9, Δ6, and Δ5 (Santos and Schulze, 2012). Among 
the three desaturases, Δ9 (stearoyl-CoA desaturase-1, SCD1) catalyzes the synthesis of 
monounsaturated fatty acids by adding one double bond to saturated fatty acids (mostly 
stearic acid), while the Δ6 and Δ5 desaturases are involved predominantly in the synthesis of 
polyunsaturated fatty acids (Nakamura and Nara, 2004). While the lipid desaturases are 
expressed in the majority of ovarian tumors (data not shown) and other cancers (Roongta et 
al., 2011), they are enriched in CSCs. SCD1 mRNA expression level was significantly 
higher in ALDH+/CD133+ vs. ALDH− /CD133− cells in both OVCAR5 (Fig. 3A) and 
COV362 (Fig. 3B) cell lines.
Small molecule inhibitors, CAY10566 which blocks SCD1 (Liu et al., 2007) and SC-26196 
which blocks Δ6 (Obukowicz et al., 1998) and shRNA based downregulation were used to 
study further the function of desaturases in ovarian CSCs. Both inhibitors significantly 
reduced the lipid unsaturation levels in OC spheroids (Fig. 3C, D). The SCD1 inhibitor was 
more potent than the Δ6 inhibitor, perhaps because monounsaturated rather than 
polyunsaturated lipids contribute more significantly to the increased unsaturation levels in 
CSCs. To measure the effects of lipid desaturase inhibitors on metabolic flux from SFAs to 
UFAs, we deployed metabolic tracing with 13C labeled glucose and glutamine (Kamphorst 
et al., 2013). The relative abundances of 13C labeled fatty acids saponfied from all lipids, 
including palmitic acid (16:0), palmitoleic acid (16:1), stearic acid (18:0), and oleic acid 
(18:1), were quantitatively analyzed by mass spectrometry. As shown in Fig. 3E-H, 
CAY10566 significantly suppressed the incorporation of 13C into UFAs (FA 16:1 and FA 
18:1), but not in SFAs (FA 16:0 and FA 18:0) in OVCAR5 spheroids. Similar effects were 
observed in cells in which SCD1 was knocked-down by shRNA compared to shRNA control 
transfected cells (Fig. S3A-D). Collectively, these data support an essential role of lipid 
desaturases for the synthesis of UFAs in CSCs.
Lipid desaturases contribute to the maintenance of cancer cell stemness
To test the functional significance of lipid desaturases relative to the known traits of CSCs, 
we measured the expression levels of CSC markers by Q-RT-PCR after desaturase inhibitor 
treatment or shRNA based downregulation. Both CAY10566 and SC-26196 reduced 
ALDH1A1 mRNA expression levels in OVCAR5, COV362 and primary ovarian cancer 
spheroids (Fig. 4A). Additionally, the expression levels of CSC-associated transcription 
factors Sox2, Nanog, and Oct-4 were decreased by treatment with the inhibitors in 
OVCAR5, COV362, and primary spheroids (Fig. 4B, S4A, B). Similarly, knock-down of 
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SCD1 by shRNA reduced the mRNA expression levels of ALDH1A1, Nanog, Sox2, and 
Oct-4, in both OVCAR5 (Fig. 4C and Fig. S4C) and COV362 spheroids (Fig. 4D and Fig. 
S4D). The reduction of stemness was further confirmed by a reduction in the ALDH+ cell 
population after treatment with the inhibitors as measured by flow cytometry (Fig. 4E). 
Overall, these data support an important role of lipid desaturases in CSC maintenance.
Inhibition of lipid desaturases prevents sphere formation in vitro and tumorigenesis in 
vivo
To determine the effect of desaturase inhibitors on the functions of CSCs, we examined the 
capacity of CSCs to form spheroids in vitro (Visvader and Lindeman, 2008a) and initiate 
tumors in vivo. Both CAY10566 (Fig. 5A) and SC-26196 (Fig. 5B) effectively suppressed 
sphere formation in OVCAR5, COV362, and primary OC cells. The suppression of sphere 
proliferation was further confirmed by using the CCK-8 assay in OVCAR5, COV362, and 
primary OC cells (Fig. S5A, B). Suppression of sphere formation was also observed in 
OVCAR5 (Fig. S5C) and COV362 cells (Fig. S5D), in which SCD1 was stably knocked 
down compared to shRNA control transfected cells. In contrast, OVCAR5 cells grown as 
monolayers (containing fewer CSCs) (Fig. S5E) and normal human dermal fibroblasts 
(NHF544) (Fig. S5F) were less sensitive to desaturase inhibitors compared to spheroids, 
supporting that lipid desaturation represents a CSC-specific target.
Next, to investigate the contribution of exogenous lipid uptake to ovarian CSCs proliferation, 
we measured sphere formation in the presence of several exogenous fatty acids (e.g., FA 
16:0, 16:1, 18:0, 18:1, 18:2, 20:4, and 22:6). Fatty acids supplementation did not alter 
(positively or negatively) sphere proliferation and addition of exogenous lipids only partially 
rescued the inhibition exerted by desaturase inhibitors on sphere formation (Fig. 5C-D, Fig. 
S6A-E). These data suggest that CSCs rely on the de novo fatty acid synthesis pathway, 
rather than on exogenous lipid uptake.
To measure the effects of desaturase inhibitors on tumor formation in vivo, we inoculated 
DMSO or inhibitor pretreated CSCs in the flanks of nude mice. Time to tumor formation 
and tumor volumes were measured. Pretreatment of ALDH+CD133+ flow sorted OVCAR5 
cells with the desaturase inhibitors CAY10566 and SC-26196 significantly delayed the 
median time to tumor initiation from 14 days (DMSO) to 39 days and 23 days (Table S2), 
respectively. Pretreatment with CAY10566 (Fig. 5E) or SC-20196 (Fig. 5F) significantly 
suppressed tumor growth. Tumor weights (mean ± SEM) were significantly reduced from 
827 ± 154 mg (DMSO) to 22 ± 12 mg by CAY10566 (Fig. S6F), and from 562 ± 160 mg 
(DMSO) to 219 ± 31 mg by SC-26196 (Fig. S6G). To verify the effects of the inhibitors on 
stemness, a tumor initiation assay was subsequently performed by using serial dilutions of 
CSCs flow sorted from OVCAR5 cell line. CAY10566 pretreatment reduced the frequency 
of tumor initiation to 20% (1 out of 5 mice) when ~500 ALDH+/CD133+ cells were used, 
40% (2 out of 5 mice) for ~1,000 CSCs, 80% (4 out of 5 mice) for ~5,000 and ~10,000 
CSCs, whereas tumors formed in all control groups (Fig. 5G). Collectively, these data 
support that blockade of lipid desaturation selectively suppresses the sphere formation and 
tumor initiation capacity of ovarian CSCs.
Li et al. Page 7
Cell Stem Cell. Author manuscript; available in PMC 2018 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Inhibition of lipid desaturases downregulates the NF-κB pathway
Having shown the effects of desaturase inhibitors on sphere formation and tumorigenesis, 
we next explored the mechanism by which lipid desaturation alters the functions of CSCs. 
We first screened the effects of the inhibitors on various CSC-related signaling mechanisms 
by using pathway specific Q-RT-PCR arrays. Both CAY10566 and SC-26196 downregulated 
key stem cell-related signaling networks in OC spheroids, particularly the NF-κB, PI3K/
Akt, Hedgehog, Notch, self-renewal, asymmetric division, migration and metastasis 
pathways (Figs 6A, B). One of the most responsive pathways to desaturase inhibition was 
NF-κB signaling, a key survival pathway in cancer, which has been also linked to cancer 
stemness (Shostak and Chariot, 2011). To confirm the suppression of NF-κB by desaturase 
inhibitors, we used an NF-κB reporter assay. Both CAY 10566 and SC-26196 significantly 
suppressed NF-κB transcriptional activity in OVCAR5, COV362 and primary OC spheres 
(Fig. 6C). Confirming suppression of NF-κB activity, the mRNA expression levels of IL-6 
(Fig. S7A) and IL-8 (Fig. S7B), known NF-κB target genes, were significantly 
downregulated by desaturase inhibitors in OC cells.
To investigate the link between NF-κB and the stem cell phenotype, p65 (relA), the active 
subunit of NF-κB, was overexpressed in ovarian cancer cells and the stem cell 
characteristics were evaluated. Indeed, overexpression of p65 increased ovarian cancer 
sphere proliferation in OVCAR5 and COV362 cells (Fig. 6D). Quantitative RT-PCR 
demonstrated that the overexpression of p65 increased ALDH1A1 expression in COV362 
cells (Fig. 6E). Consistently, a small molecule inhibitor of NF-κB, 
dimethylaminoparthenolide (DMAPT) (Shanmugam et al., 2011), reduced ALDH1A1 
expression in primary OC spheroids (Fig. 6F). Together, these data support that NF-κB, as 
an important pathway downregulated by desaturases inhibition, is invovled in stem cell 
regulation.
NF-κB and ALDH regulate lipid unsaturation
To further understand the mechanism by which NF-κB is linked to lipid desaturation and 
ovarian cancer cell stemness, ovarian cancer spheres were treated with the NF-κB inhibitor. 
DMAPT decreased both lipid unsaturation levels (Fig. 7A) as well as SCD1 mRNA 
expression levels in primary ovarian cancer spheres (Fig. 7B). Next, to investigate whether 
NF-κB directly regulates the expression of desaturases, a promoter search motif identified 
two putative p65 (relA) binding sites at position −215 to −206 and at position +179 to 188 in 
the SCD1 promoter (Fig. S7C). The direct interaction between p65 and the SCD1 promoter 
region was then confirmed by chromatin immunoprecipitation (ChIP) using a p65 antibody 
in OVCAR5 cells stably transduced with pQCXIP vector or pQCXIP/p65 (Fig. 7C). 
Consistent with the proposed direct transcriptional regulatory role of NF-κB, the 
overexpression of p65 significantly upregulated the expression levels of SCD1 in OVCAR5 
and COV362 spheroids (Fig. 7D), IL8, a known p65 target gene was used as a positive 
control in these experiments (Fig. S7D). Together these results demonstrate that NF-κB 
directly regulates SCD1 expression and promotes CSC characteristics.
We also detected increased lipid unsaturation in ALDH+ (single marker) OC cells (Fig. 
S7E). ALDH1A1 functions as a detoxification enzyme and is implicated in the conversion of 
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retinol to retinoic acid (Ma and Allan, 2011; Marcato et al., 2011). ALDH1A1 is recognized 
as a stem cell marker in several tumor types, including ovarian cancer (Silva et al., 2011), 
but its involvement remains unclear. It has been proposed that its role in the maintenance of 
CSCs is related to regulation of cell differentiation mediated by retinoic acid signaling 
(Chute et al., 2006; Ginestier et al., 2009). To determine the potential mechanism by which 
ALDH1A1 may be involved in regulating lipid desaturation, we used a recently identified 
and highly specific ALDH1A1 inhibitor, CM037 (Condello et al., 2015). Treatment with 
CM037 potently decreased the mRNA expression levels of SCD1 in primary OC spheres 
(Fig. S7F), supporting a link between the two pathways. Additionally, CM037 decreased 
lipid unsaturation levels in COV362 (Fig. 7E), OVCAR5 (Fig. S7G) and primary OC 
spheres (Fig. S7H). Because ALDH1A1 regulates retinoic acid signaling (Ma and Allan, 
2011), we next tested whether its effects on lipid unsaturation can be reversed by retinoic 
acid. The lipid unsaturation levels reduced by CM037 were successfully rescued by the 
addition of retinoic acid in COV362 (Fig. 7E), OVCAR5 (Fig. S7G) and primary OC 
spheres (Fig. S7H). Taken together, these data suggest a role of ALDH1A1 in the regulation 
of lipid desaturation in ovarian CSCs mediated through retinoic acid signaling.
As summarized in Fig. 7F, our studies revealed a functional role of altered lipid metabolism 
in ovarian CSCs. Through de novo lipogenesis and subsequent lipid desaturation, the 
unsaturated fatty acids promote activation of NF-κB, a key pathway involved in maintaining 
the CSC phenotype. In turn, the NF-κB pathway modulates the expression levels of lipid 
desaturases at the transcriptional level. Together, our data support a positive feedback loop 
between lipid metabolism and NF-κB signaling in regulating OC cell stemness.
DISCUSSION
Since the first use of CD34 and CD38 as surface markers of leukemia stem cells, efforts to 
search for bona fide markers of CSCs have intensified. The lack of reliable methods to 
identify and isolate CSCs has remained one of the biggest challenges facing CSC research 
(Clevers, 2011). Current methods to enrich or isolate CSCs include surface marker labeling 
for flow cytometry sorting, side population sorting, and sphere culture (Zhou and Zhang, 
2008). Surface markers have been widely used as the standard method to isolate CSCs. 
Some intracellular markers, such as aldehyde dehydrogenase (ALDH) have also been used 
alone or in combination with other markers. However, many of the CSC markers selected 
based on empirical assays are not necessarily linked to clear functional roles (Clevers, 2011; 
Visvader and Lindeman, 2008b). Recently, Heeschen and colleagues reported that a strong 
intracellular autofluorescence signal, originating from riboflavin accumulation, can be used 
as a biomarker for epithelial CSCs (Miranda-Lorenzo et al., 2014). However, the precise 
function of the accumulated fluorophore remains unknown and the level of the 
autofluorescence signal can be easily altered by environmental changes, limiting its use as a 
reliable marker for CSCs.
Our study proposes a stable, universal and functional metabolic marker for ovarian CSCs. 
By using Raman spectroscopic imaging, we identified an increase of lipid unsaturation 
levels in the lipid droplets of single ovarian CSCs derived from cell lines and human 
specimens. As the site for neutral lipid storage, LDs buffer the synthesis and consumption of 
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lipids, which renders their composition relatively stable over time. Since unsaturated lipids 
are primarily derived from de novo synthesis, they are not easily subject to environmental 
changes. Indeed, we observed consistently increased lipid unsaturation in CSCs regardless 
of culture conditions (e.g. serum enriched or serum free media) in OC cell lines and human 
primary malignant cells. Raman spectral measurement is based on the ratio of unsaturated 
lipids to total lipids, instead of the absolute amount of unsaturated lipids, eliminating the 
change induced by the total lipids amount. It is possible that increased unsaturated lipids are 
detectable in CSCs from other cancer types (our unpublished data in pancreatic and 
leukemia cells) and future studies will address this concept more broadly. Combining this 
marker with Raman spectroscopic imaging could lead to a reliable and universal method for 
in situ detection of CSCs. Further refinement of Raman spectroscopic imaging based 
techniques, such as coherent Raman scattering flow cytometry (Camp et al., 2009; Camp et 
al., 2011; Wang et al., 2008), would allow fast, noninvasive detection and isolation of CSCs.
As shown by single cell spectroscopic imaging, CSCs are characterized by a higher 
conversion rate from saturated to unsaturated lipids, compared to differentiated cancer cells, 
a process mediated by fatty acid desaturases. We further observed that lipid desaturases are 
enriched in CSCs and can be targeted. By measuring key characteristics of stem cells in vitro 
and in vivo, including sphere formation and tumor initiation, we showed that lipid 
desaturases are critical to maintaining CSCs, suggesting that unlike most surface markers, 
unsaturated lipids possess definitive functions. Our data support further investigation of lipid 
desaturases as CSC specific targets and development of combination strategies using these 
inhibitors with standard chemotherapy targeting the non-CSC population to improve disease 
control.
Finally, we identified a positive feedback loop involving the NF-κB pathway, ALDH1A1 
and lipid desaturases in ovarian CSCs. A functional link between NF-κB as the master 
regulator of inflammation converging pathways and cancer has been established for other 
tumor models (Karin et al., 2002; Shostak and Chariot, 2011) and activation of NF-κB in 
stem cells has been recently reported (Jia et al., 2015). Here, we link NF-κB, lipid 
desaturases, and CSCs. Our data support that NF-κB regulates SCD1 at the transcriptional 
level, that NF-κB activation promotes ovarian sphere proliferation, and that in turn 
desaturase inhibition blocks NF-κB activity and reduces cancer stemness. Interestingly, we 
show that IL-6, one of the known targets genes of NF-κB, is potently downregulated by the 
inhibitors. IL-6 has been recently linked to cancer stemness in multiple cancer models 
(Sansone et al., 2016; van der Zee et al., 2015). The exact mechanism by which NF-κB is 
inactivated by desaturase inhibitors in CSCs remains undefined. A possible explanation 
could be that the reduction of unsaturated lipids induced by the inhibitors directly blocks 
NF-κB given that unsaturated fatty acids, such as arachidonic acid (Camandola et al., 1996), 
oleic and linoleic acid (Poletto et al., 2015), are known activators of the complex. Besides 
the NF-κB pathway, our PCR array assay showed that disruption of lipid desaturation also 
impaired other stem cell associated pathways, which may contribute additionally to 
inhibiting CSCs. Unsaturated lipids are also known to modulate membrane fluidity 
(Nakamura and Nara, 2004), which could contribute to altered oncogenic signaling and 
impairment of stemness.
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In all, our results discovered a new functional marker of ovarian CSCs, intimately linked to 
the NF-κB survival pathway and lipid metabolism. We propose that this marker represents a 
targetable metabolic vulnerability of recalcitrant stem cells, which should be exploited to 
improve the outcome of existing therapies.
STAR METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests may be directed to, and will be fulfilled by the Lead 
Contact, Ji-Xin Cheng (jcheng@purdue.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines—Human ovarian cancer cell lines COV362 and OVCAR5 were a gift from Dr. 
Kenneth P. Nephew (Indiana University, Bloomington, IN). Both cell lines were tested to be 
mycoplasma negative and OVCAR5 cell line was authenticated by Short Tandem Repeat 
(STR) analysis. COV362 cells were cultured in DMEM high glucose medium supplemented 
with 10% FBS and 100 units/mL penicillin and 100 μg/mL streptomycin. OVCAR5 cells 
were grown in D-MEM (high glucose), 10% fetal bovine serum (FBS), 0.1 mM Non-
Essential Amino Acids (NEAA), 2 mM L-glutamine, and antibiotics. All cells were cultured 
at 37°C in a humidified incubator with 5% CO2 supply.
Primary human cells—De-identified malignant ascites fluid specimens from ovarian 
cancer patients (n = 4) were obtained at the Indiana University Simon Cancer Center 
(IUSCC) under an IRB approved protocol (IUCRO#505). Additional information regarding 
subjects’ clinical history is provided in Table S1. The normal human dermal fibroblasts were 
obtained and provided by Dr. Dan Spandau (IUSCC, Indianapolis, IN) after isolation from 
foreskin tissue. The procedures related to human tissue samples procurement were approved 
by the Indiana University School of Medicine IRB.
Tumor cells were purified as previously described (Condello et al., 2015). After 
centrifugation at 1,200 rpm for 5 min, 25,000 ascites derived tumor cells were cultured as 
monolayers in DMEM medium supplemented with 10% FBS and antibiotics or suspended in 
Mammocult Complete medium (StemCell Technologies) and plated in ultra-low adherent 
surfaces to allow spheroid formation.
Subcutaneous xenograft mouse model—All animal experiments were conducted 
following protocols approved by Purdue Animal Care and Use Committee (PACUC). 5~6 
week-old female athymic nude mice (strain Hsd:Athymic Nude-Foxn1nu) (Envigo) were 
used to establish the tumor subcutaneous xenograft model. Housing and husbandry of the 
nude mice were conducted by the staffs at the animal facility of Purdue University following 
PACUC regulations.
METHOD DETAILS
Sphere formation assay—FACS-sorted ALDH+/CD133+ OC cell lines or primary cells 
were seeded as single cell suspension at a concentration of 10,000 cells/well in 96-well 
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ultra-low attachment plates (Corning, Corning, NY, USA) in Mammocult complete medium 
(StemCell Technologies). After 6 days, spheroids were counted after centrifugation at 300×g 
for 5 minutes. Cell numbers were also quantified by the CCK-8 assay (Dojindo Molecular 
Technologies, Rockville, MD). All assays were performed in four replicates.
Aldefluor assay and Fluorescence-Activated Cell Sorting—ALDH and CD133 
double positive or negative cells were isolated by fluorescence-activated cell sorting (FACS) 
using the Aldefluor assay kit (Stemcell Technologies) and the allophycocyanin (APC) 
conjugated CD133/1 (AC133) antibody (Miltenyi Biotec, Auburn, CA, USA). Briefly, 
dissociated monolayer single cells were resuspended in Aldefluor assay buffer containing 
the ALDH1 substrate, bodipyaminoacetaldehyde (BAAA), at 1.5mM. After incubation for 
45 min at 37 °C, the cells were centrifuged at 1,200 rpm for 5 min at 4 °C, washed twice 
with Aldefluor assay buffer and incubated in the same buffer supplemented with 0.5% 
bovine serum albumin BSA and anti-CD133/1 (AC133) antibody (1:10 dilution) for 30 min 
on ice. The test ALDH+/CD133+ population was gated using control cells incubated under 
an identical condition in the presence of a 10-fold molar excess of the ALDH inhibitor 
(DEAB), and anti-mouse IgG1 isotype control APC-conjugated antibody (1:10 dilution) 
(Miltenyi Biotec). FACS was performed using a FACS Aria II flow cytometer (BD 
Biosciences, San Jose, CA) under sterile conditions.
Hyperspectral stimulated Raman scattering (SRS) imaging—Hyperspectral SRS 
imaging was done with a spectral focusing method following previously published protocol 
(Fu et al., 2013; Liu et al., 2015). Briefly, the Raman shift is tuned by controlled the 
temporal delay between two chirped femtosecond pulses. In our scheme, a femtosecond 
laser (Coherent) operating at 80 MHz provided the pump and Stokes laser source. With 
pump beam tuned to 810 nm, Stokes beam was tuned to 1055 nm to cover the C-H vibration 
region. The Stokes beam was modulated at 2.3 MHz by an acousto-optic modulator (1205-
C, Isomet). After combination, both beams were chirped by two 12.7 cm long SF57 glass 
rods and then sent to a laser-scanning microscope. A 60× water immersion objective (NA = 
1.2, UPlanApo/IR, Olympus) was used to focus the light on the sample, and an oil condenser 
(NA = 1.4, U-AAC, Olympus) was used to collect the signal.
To obtain a hyperspectral SRS image, a stack of 50 images at different pump-Stokes 
temporal delay was recorded. The temporal delay was controlled by an automatic stage, 
which moved forward with a step size of 10 μm, corresponding to ~5 cm−1. To calibrate the 
Raman shift to the temporal delay, standard chemicals with known Raman peaks in C-H 
region from 2800 to 3050 cm−1, including DMSO, methanol, oleic acid, and linolenic acid, 
were used. To eliminate the power difference at different Raman shift, SRS signal was 
normalized by two-photon absorption signal from Rhodamine 6G, the cross-section of 
which is considered constant in this small region. The spectral resolution of the system was 
estimated to be ~25 cm−1. Hyperspectral SRS images were analyzed using software ImageJ.
Spontaneous Raman spectroscopy—Confocal Raman spectral analysis from 
individual LDs was performed as described previously (Slipchenko et al., 2009). A 5-
picosecond laser at 707 nm was used as excitation beam for Raman spectral acquisition. 
Acquisition time for a typical spectrum from individual LDs was 20 seconds, with the beam 
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power maintained around 15 mW at the sample. For each specimen, at least 10 spectra from 
individual LDs in different locations or cells were obtained. The spectra were analyzed using 
software Origin 8.5. The background was removed manually, and peak height was measured.
Mass spectrometry analysis of fatty acids—OVCAR5, COV362 and primary human 
OC cells were cultured under serum-free conditions either as monolayers or spheres. For 
the 13C tracing experiments, cells were seeded in ultra-low adherence plates and grown in 
sphere culture medium (containing glucose and glutamine) supplemented with additional 25 
mM Glucose (U-13C6, 99%) and 4 mM L-Glutamine (U-13C5, 99%). The cells were grown 
as spheres for 6 days with or without inhibitor treatment or SCD1 shRNA knock-down. 
Spheres were collected by centrifuging at 200 rpm for 1 min to separate from floating single 
cells. All the experiments were conducted in three replicated sets of samples.
Free fatty acid extraction was performed following previous protocol (Ma and Xia, 2014). 
Cell pellets were resuspended in 300 μL PBS, mixed with 1 ml methanol and acidified with 
HCl to 25 mM final concentration. After addition of 1 ml isooctane was added, and samples 
were vortexed and centrifuged at 3,000 g for 1 min. The top layer was transferred to a glass 
tube and dried under vacuum. Extracted lipids were re-dissolved in 100 μl acetone: water 
(1:1). Electrospray Ionization-Mass Spectrometry (ESI-MS) analysis of fatty acids was 
conducted.
Extraction and preparation of saponified fatty acids were performed following previous 
protocol (Kamphorst et al., 2013; Yang et al., 2007). Briefly, cells were lysed in 1 ml of cold 
50:50 MeOH/H2O solution with 0.1 M HCl, mixed with 0.5 ml chloroform, and centrifuged 
at 16,000 g for 5 min. The lower phase was transferred to glass vials and dried under N2 
flow. Dried lipid extract was reconstituted into 90:10 MeOH/H2O containing 0.3 M KOH, 
saponified at 80 °C for 1 h, and then acidified with 0.1 mL of formic acid. Fatty acids were 
extracted twice with 1 mL of hexane, dried under N2 flow. For quantitative analysis, each 
fatty acid (Sigma) at known concentration were used as internal standards. Liquid 
Chromatography-Mass Spectrometry (LC-MS) analysis of fatty acids was performed 
following previously described protocol (Yang et al., 2007). For 13C tracing experiments, 
fatty acids (e.g., FA 16:0, 16:1, 18:0, 18:1) with various numbers of 13C labeling were 
analyzed. The natural isotopic abundances were correlated following described protocol 
(Tumanov et al., 2015).
Tumor initiation assays in subcutaneous xenograft mouse model—For tumor 
formation and growth experiment, FACS-isolated ALDH+/CD133+ OVCAR5 cells were 
seeded at a density of 20,000 cells/well in non-adherent ultra-low plates in Mammocult 
complete medium (StemCell Technologies), and treated with DMSO, CAY10566 or 
SC26196 respectively at a concentration of 1 μM for 6 days. Spheres were collected and 
mixed with equal volume of Matrigel Matrix (Corning, Cat# 356234) prior to subcutaneous 
injection. An equal number of DMSO and inhibitors treated spheres were injected 
subcutaneously into the left and right flank of 5~6 week-old female athymic nude mice 
(Envigo), respectively, with 8 mice randomly assigned to each group. Tumors were 
measured twice a week using calipers. Tumor volume was calculated as 1/2 × L × W2, 
where L stands for the length, and W for the width measured by a caliper in mm. Time to 
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tumor formation was defined as the time from cell inoculation to the time when tumors were 
first detected. At the end of the study (e.g. when at least one tumor reached 2,000 mm3), 
mice were euthanized, tumors were harvested, measured and weighed.
For tumor initiation assay, FACS-isolated ALDH+/CD133+ OVCAR5 cells were seeded in 
non-adherent ultra-low 96-well plates at densities of 20000, 10000, 5000, 1000, and 500 
cells per well. The cells were treated with DMSO or CAY10566 at a concentration of 1 μM 
and grown as spheroids for 6 days. Tumor cell inoculation was performed as described 
above with 5 mice randomly assigned to each group. Tumor initiation was determined ~30 
days after tumor cell inoculation.
Generation of SCD1 stably knock-down cells—OVCAR5 and COV362 cells were 
transfected with SCD1 targeting shRNA lentiviral particles (Santa Cruz Biotechnology, Inc., 
Dallas, TX, sc-36464-V) following the manufacturer’s protocol. Scrambled shRNA 
lentiviral particles (Santa Cruz, sc-108080) were used as a control. Stably transfected cells 
were selected with 0.5 μg/ml puromycin.
Stable retroviral transduction—The active p65 (Rel A) subunit of NF-κB subcloned 
into the pQCXIP retroviral vector (Chua et al., 2007) was transduced in OVCAR5 and 
COV362 cells and pooled colonies were selected with puromycin. Transduction of the 
empty vector was performed in parallel.
Gene reporter assay—Dual-Luciferase Assay (Promega, Madison, WI) quantified NF-
κB activity in COV362, OVCAR5 and primary cells grown as spheroids, according to the 
manufacturer’s instructions. In brief, cells were plated in ultra-low adherence plates in 
Mammocult complete medium and transiently co-transfected with the NF-κB promoter 
luciferase and renilla plasmids at the ratio of 10:1 by using DreamFect Gold transfection 
reagent (OZ Biosciences, Marseille, France). After 24 h, cells were treated with the SCD1 
inhibitor CAY10566 or the Δ6 inhibitor SC26196 at a concentration of 1.0 μM for 48 h. 
Luminescence was measured by using the TD-20/20 Luminometer (Turner Biosystems, 
Madison, WI). Experiments were performed in triplicate and repeated two times in 
independent conditions. To control for transfection efficiency, NF-κB luminescence was 
normalized to renilla activity.
Reverse transcription-PCR (RT-PCR)—Total RNA was extracted from OC cell lines or 
primary cells by using RNA STAT-60 (Tel-Test Inc., Friendswood, TX) and reverse 
transcribed using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). The reverse 
transcriptase product (1 μL) and primers (Table S3) were heated at 94 °C for 10 min, 
followed by 40 cycles of amplification at 94 °C for 15 secs and 60 °C for 1 min. At the end 
of the PCR reaction a melting curve was generated and the cycle threshold (Ct) was recorded 
for the reference and control genes. The relative expression of different transcripts was 
calculated as ΔCt and normalized by subtracting the Ct of target genes from that of the 
housekeeping control (18S). Real-time PCR was carried out on an ABI Prism 7900 platform 
(Applied Biosystems, Grand Island, NY) using the iTaq universal SYBR Green super mix 
(Bio-Rad, Hercules, CA, USA). Human IL6 gene expression was detected using TaqMan® 
Gene Expression Assay (Hs00985639_m1) and TaqMan® Gene Expression Master Mix 
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(Applied Biosystems). Results are presented as means + SEM of replicates. Measurements 
were performed in duplicate and experiments were run three times in independent 
conditions.
The human cancer stem cells RT2 Profiler PCR Array was purchased from SA Bioscience 
and real-time PCR was performed on ABI Prism 7900 HT (Applied Biosystems), according 
to the manufacturer’s instructions. Data analysis was performed based on the ΔΔCt method 
with normalization of the raw data to the housekeeping genes using a Microsoft excel 
algorithm provided by the manufacturer. An ontology classification assignment for each 
gene was performed, and fold-changes were calculated and expressed as percent of 
composition for each represented pathway in control versus treated spheres.
Chromatin immunoprecipitation (ChIP)—Chromatin immunoprecipitation was 
performed by using a kit from EMD Millipore (Billerica, MA USA) according to the 
manufacturer’s instructions, with some modifications. In brief, 107 OVCAR5 cells stably 
transduced with pQCXIP and pQCXIP/p65 were fixed in 1% formaldehyde for 10 minutes 
at 37°C to cross-link histones to DNA. Cells were washed twice with ice-cold phosphate-
buffered saline (10 mmol/L Na2HPO4, 2 mmol/L NaH2PO4, 137 mmol/L NaCl, 2.7 
mmol/L KCl) containing protease inhibitors (1 μg/mL aprotinin, 1 μg/mL leupeptin, and 1 
mmol/L phenylmethylsulfonyl fluoride) and lysed for 10 minutes in SDS buffer (1% SDS, 
50 mM Tris [pH 8.1], 10 mM EDTA). Cell lysates were sonicated on ice with 3 sets of 10-
second pulses using a Sonic Dismembrator Model 100 (Fisher Scientific, Pittsburgh, PA) set 
at 30% of maximum power. The soluble chromatin was then centrifuged, resuspended in 
ChIP dilution buffer (final concentration of 15 mmol/L Tris-HCl [pH 8.1], 2 mmol/L EDTA, 
150 mmol/L NaCl, 0.1% SDS, 1% Triton X-100) containing protease inhibitors, and one 
tenth of the supernatant was used as DNA input control. The remaining volume of ChIP 
solution was pre-cleared by incubation with sheared salmon sperm DNA/protein A–agarose 
50% slurry and incubated with rabbit immunoglobulin G (IgG) or rabbit polyclonal anti-NF-
κB p65 antibody (Cell Signaling Technology Inc., 1:100 dilution) overnight at 4°C with 
agitation. The immunoprecipitated complexes were incubated with protein A slurry and then 
washed successively with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 
mM Tris-HCl [pH 8.1], 150 mM NaCl), high-salt buffer (500 mM NaCl), LiCl buffer (0.25 
M LiCl, 1% IGEPAL-CA630, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl [pH 8.1]), 
and Tris-EDTA (pH 8.0), and then were eluted with 1% SDS, 100 mM NaHCO3 buffer. The 
cross-linking of protein-DNA complexes was reversed by incubation with 5 M NaCl at 65°C 
for 4 h, and DNA was digested with 10 mg of proteinase K (Sigma)/ml for 1 h at 45°C 
before DNA extraction.
To detect whether NF-κB p65 binds to the SCD1 promoter, input and immunoprecipitated 
chromatin was extracted with QIAquick PCR purification kit (QIAGEN, Valencia, CA) by 
following the manufacturer’s protocol and subjected to PCR amplification using primers 
designed for the putative p65 binding region 1 (SCD F1/R1) and putative p65 binding region 
2 (SCD F2/R2) in the SCD1 promoter (Table S3). The PCR products were analyzed by real-
time PCR and normalized by subtracting the Ct of target genes from that of the input/starting 
material. The expression levels of target genes were calculated as fold changes compared to 
the signal of DNA immunoprecipitated with IgG (control). As a positive control, DNA 
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immunoprecipitated with p65 antibody was amplified using primers for the known sequence 
of the IL8 promoter (Table S3) (Li et al., 2012), known NF-κB target gene. As a negative 
control, DNA immunoprecipitated with p65 antibody was amplified with primers designed 
for the SCD1 promoter, upstream of the putative p65 binding sites (SCD upstream). All the 
measurements were performed in triplicates.
QUANTIFICATION AND STATISTICAL ANALYSIS
Hyperspectral SRS images were quantitatively analyzed using ImageJ software. Raman 
spectroscopy data were analyzed using Origin 8.5 software. Mass spectrometry data were 
analyzed using Agilent MassHunter Workstation Software Quantitative Analysis. One-way 
ANOVA or Student’s t test were used for comparisons between groups. Results are 
represented as means +/± SEM or as indicated. Each experiment was performed with a 
minimum of three biological replicates; exact numbers are indicated in associated figure 
legends. Significant differences were considered at * P < 0.05, ** P < 0.01, and *** P < 
0.001. n.s. means not significant.
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Figure 1. Increased lipid unsaturation level in sorted ALDH+/CD133+ ovarian cancer cells
(A) Representative hyperspectral SRS images of flow-sorted ALDH−/CD133− and ALDH+/
CD133+ COV362 cells. Images at 2900 cm−1, 3002 cm−1 and the intensity ratio image 
between 3002 and 2900 cm−1 are shown. Scale bars: 10 μm. (B) Average SRS spectra from 
the lipid droplets in ALDH−/CD133− (n=3) and ALDH+/CD133+ cells (n=8). Shaded area 
indicates the standard deviation (SD) of SRS spectral measurement from different cells. (C) 
Spontaneous Raman spectra taken from LDs in ALDH−/CD133− and ALDH+/CD133+ 
sorted COV362 cells. The spectra were normalized by the height of the Raman peak at 1450 
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cm−1. The differences at 1264 cm−1, 1660 cm−1, and 3002 cm−1 were highlighted in gray. 
(D) Scatter plot of Raman spectra height ratio between the peaks at 3002 cm−1 and 1450 
cm−1 in ALDH−/CD133− and ALDH+/CD133+ COV362 cells. Each dot represents a single 
cell, and the bars indicate means ± SEM; P = 0.0005. (E) Raman spectra taken from LDs in 
ALDH−/CD133− and ALDH+/CD133+ OVCAR5 cells. The spectra were normalized by the 
height of peak at 1450 cm−1. The differences at 1264 cm−1, 1660 cm−1, and 3002 cm−1 were 
highlighted in gray. (F) Scatter plot of Raman spectra height ratio between the peaks at 3002 
cm−1 and 1450 cm−1 in ALDH−/CD133− and ALDH+/CD133+ OVCAR5 cells. Each dot 
represents a single cell, and the bars indicate means ± SEM; P = 0.0012. See also Figure S1, 
Movie S1, and Movie S2.
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Figure 2. Increased lipid unsaturation level in spheres compared to monolayer cultures
(A) Representative hyperspectral SRS images of COV362 cells grown as monolayers and 
spheres. Images at 2900 cm−1, 3002 cm−1 and the intensity ratio between 3002 cm−1 and 
2900 cm−1 are shown. Scale bars: 10 μm. (B) Average SRS spectra from the lipid droplets in 
COV362 monolayer (n=6) and spheres (n=6). Shaded area indicates the standard deviation 
of SRS spectral measurement from different cells. (C) Quantitation of the height ratio 
between the =C-H peak at 3002 cm−1 and the C-H bending peak at 1450 cm−1 based on 
Raman spectral measurements in monolayers and spheres derived from COV362, OVCAR5 
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and primary cells isolated from malignant OC ascites of four patients. The data are shown as 
means + SEM; n ≥ 10. (D) LC-MS measurement of fatty acids saponfied from all lipids 
extracted from OVCAR5 monolayer cultures and spheres. Fatty acids levels were 
normalized by total protein amount extracted from an equal number of cells. (E) 
Quantitation of the ratios of unsaturated fatty acid (UFA) to saturated fatty acid (SFA) in 
OVCAR5 monolayer and spheres. The data are shown as means + SD; n = 3. * P < 0.05, ** 
P < 0.01, *** P < 0.001. See also Figure S2, Table S1, Movie S3, and Movie S4.
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Figure 3. Increased desaturation in CSCs is due to lipid desaturases
(A, B) Quantitative RT-PCR measurement of SCD1 expression levels in ALDH−/CD133− 
and ALDH+/CD133+ OVCAR5 and COV362 cells. The data are shown as means + SEM; n 
= 3. (C, D) Raman spectral measurement of lipid unsaturation level in primary spheres 
treated with the SCD1 inhibitor CAY10566 or Δ6 inhibitor SC-26196 at 1.0 μM for 6 days. 
The data are shown as means + SEM; n ≥ 10. (E-H) LC-MS analysis of relative abundance 
of 13C incorporation into fatty acids 16:0, 16:1, 18:0 and 18:1 saponified from all lipids in 
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OVCAR5 spheroids treated with DMSO or 1 μM CAY10566 for 6 days. The data are shown 
as means + SD; n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001. See also Figure S3.
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Figure 4. Inhibition of lipid desaturation impairs ovarian cancer cell stemness
(A) RT-PCR measurement of ALDH1A1 mRNA expression level in OVCAR5, COV362, 
and primary spheroids. (B) RT-PCR measurement of Sox2 mRNA expression level in 
OVCAR5, COV362, and primary spheroids. Treatment with CAY10566 or SC-26196 in 
spheroids was done at a concentration of 1.0 μM for 6 days. (C, D) RT-PCR measurement of 
SCD1, ALDH1A1 mRNA expression level in OVCAR5, COV362 cells stably transfected 
with scrambled control shRNA (shCtr) or SCD1 shRNA (shSCD). The data were shown as 
means + SEM; n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001. (E) Flow cytometry analysis of 
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ALDH+ cells sorted from OVCAR5, COV362 and primary cells after CAY10566 or 
SC-26196 treatment at a concentration of 1.0 μM for 6 days. DEAB was used as negative 
control. See also Figure S4.
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Figure 5. Inhibition of lipid desaturation prevents sphere growth in vitro and tumor formation in 
vivo
(A, B) Representative images of OVCAR5, COV362 and primary spheres treated with 
CAY10566 or SC-26196 at indicated concentrations for 6 days. (C, D) Sphere proliferation 
of COV362 cells supplemented with fatty acid (C) 18:0 and (D) 18:1 at indicated 
concentrations and treated with CAY10566 or SC-26196 at 1 μM for 6 days. Comparisons 
were performed between inhibitors treated group and DMSO treated group under the same 
concentrations of fatty acid supplementation (P value indicated by *), or between DMSO 
Li et al. Page 28
Cell Stem Cell. Author manuscript; available in PMC 2018 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
groups under different concentrations of fatty acid supplementation (P value indicated by #). 
The data are normalized to the blank control (no fatty acid supplementation and treated with 
DMSO) and shown as means + SEM; n = 4. (E, F) Growth curves of xenografts derived 
from (E) DMSO (n = 7) or CAY10566 (n = 6), and (F) DMSO (n = 8) or SC-26196 (n = 8) 
pretreated OVCAR5 cells grown in spheroids. The data are presented as means + SEM. 
Inset: tumor size comparison at the end of study (42 days after tumor cells inoculation). 
Upper: DMSO; lower: treated. * P < 0.05, ** P < 0.01, *** P < 0.001. (G) Tumor initiation 
assay using serial dilution of OVCAR5 cells pretreated with DMSO or CAY10566 at 1 μM. 
Cells were counted and then cultured for 6 days with the presence of DMSO or CAY10566 
to allow sphere formation before injected into the mice. 5 mice were used for each group. 
See also Figure S5, Figure S6, and Table S2.
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Figure 6. Inhibition of lipid desaturation down-regulates the NF-κB pathway
CSC genes preferentially down-regulated by (A) CAY10566 treatment compared to control 
(DMSO) (> 2.0 fold) or (B) SC-26196 treatment compared to control (DMSO) (> 2.0 fold) 
were quantified by RT2 Profiler PCR array in OVCAR5 spheroids treated with CAY10566 at 
1 μM for 6 days. Pie chart analysis showing the downregulated genes (% of total) for each 
represented pathway in control vs. treated spheres. (C) NF-κB promoter activity measured 
by gene reporter assay in OVCAR5, COV362 and primary OC cells spheroids treated with 
CAY10566 or SC-26196 at 1 μM for 6 days. (D) Proliferation of OVCAR5 and COV362 
cells stably transduced with empty vector (pQCXIP) or with pQCXIP/p65 and grown as 
spheroids. The data are shown as means + SEM; n = 4. (E) RT-PCR measurement of 
ALDH1A1 in COV362 spheroids stably transduced with empty vector (pQCXIP) or with 
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pQCXIP/p65. (F) RT-PCR measurement of ALDH1A1 mRNA levels in primary OC 
spheroids treated with NF-κB inhibitor, DMAPT, at indicated concentrations. The data are 
shown as means + SEM; n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001. See also Figure S7A-
B.
Li et al. Page 31
Cell Stem Cell. Author manuscript; available in PMC 2018 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. NF-κB and ALDH1A1 promote lipid unsaturation
(A) Raman spectral measurement of lipid unsaturation level in OC spheroids treated with the 
NF-κB inhibitor, DMAPT, at indicated concentrations. n ≥ 10. (B) RT-PCR measurement of 
SCD1 mRNA levels in primary OC spheroids treated with DMAPT at indicated 
concentrations. n = 3. (C) ChIP demonstrates that p65 binds the SCD1 promoter region. 
Immunoprecipitated chromatin with an antibody against p65 was used for quantitative PCR 
amplification. Primers flanking two predicted p65-binding regions of the SCD1 promoter 
(−215 to −206 and +179 to +188 bp) were used. Positive control was p65 antibody-
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immunoprecipitated chromatin amplified with primers for the IL8 promoter, a known p65 
target. Negative controls were chromatin immunoprecipitated with IgG and amplified with 
SCD1 promoter primers and chromatin immunoprecipitated with p65 antibody and 
amplified with primers to a region in the SCD1 promoter located upstream of the predicted 
p65 binding sites. (D) Quantitative RT-PCR measured SCD1 mRNA expression levels in 
COV362 spheroids transfected with pQCXIP vector or pQCXIP/p65. The data are shown as 
means + SEM; n = 3. (E) Raman spectral measurement of lipid unsaturation level in 
COV362 spheroids treated with ALDH1A1 inhibitor, CM037, or CM037 and retinoic acid 
for 6 days. The data are shown as means + SEM; n ≥ 10. * P < 0.05, ** P < 0.01, *** P < 
0.001, n.s: not significant. (F) The proposed mechanism by which lipid desaturation is 
linked to cancer cell stemness. See also Figure S7C-H.
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